Financhill
Sell
18

ZNTL Quote, Financials, Valuation and Earnings

Last price:
$1.40
Seasonality move :
-19.35%
Day range:
$1.39 - $1.42
52-week range:
$1.01 - $4.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.71x
P/B ratio:
0.40x
Volume:
393.5K
Avg. volume:
618.4K
1-year change:
-58.38%
Market cap:
$100.4M
Revenue:
$67.4M
EPS (TTM):
-$2.08

Earnings Data

Next earnings date for ZNTL
Mar 26
2026
Most recent earnings per share
-$0.37
Beat by $0.11
(Nov 10/2025)
Consensus Estimate
-$0.48
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ZNTL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/26/2026 Q4 -- -- -- -$0.40 --
11/10/2025 Q3 -- -- -$0.37 -$0.48 $0.11
08/08/2025 Q2 -- -- -$0.37 -$0.52 $0.15
05/07/2025 Q1 -- -- -$0.67 -$0.61 -$0.07
03/26/2025 Q4 -- $26.9M -$0.67 -$0.68 $0.02
11/12/2024 Q3 -- -- -$0.56 -$0.87 $0.31
08/09/2024 Q2 -- -- -$1.24 -$0.83 -$0.42
05/07/2024 Q1 $11.7M $40.6M $0.14 -$0.74 $0.88
02/27/2024 Q4 -- -- -$0.86 -$0.84 -$0.02
11/06/2023 Q3 -- -- -$0.79 -$0.94 $0.15
08/09/2023 Q2 -- -- -$1.85 -- --
05/10/2023 Q1 -- -- -$1.07 -- --
02/24/2023 Q4 -- -- -$0.93 -- --
11/09/2022 Q3 -- -- -$0.96 -- --
08/09/2022 Q2 -- -- -$1.34 -- --
05/05/2022 Q1 -- -- -$1.31 -- --
02/24/2022 Q4 -- -- -$1.11 -- --
11/10/2021 Q3 -- -- -$0.09 -- --
08/12/2021 Q2 -- -- -$1.34 -- --
05/17/2021 Q1 -- -- -$1.24 -- --
03/25/2021 Q4 -- -- -$0.98 -- --
11/09/2020 Q3 -- -- -$0.91 -- --
08/13/2020 Q2 -- -- -$0.78 -- --
05/15/2020 Q1 -- -- -$0.45 -- --
12/31/2019 Q4 -- -- -$0.40 -- --
09/30/2019 Q3 -- -- -$2.20 -- --
06/30/2019 Q2 -- -- -$0.29 -- --
03/31/2019 Q1 -- -- -$0.23 -- --

Zentalis Pharmaceuticals, Inc. Earnings Questions

  • How Much did Zentalis Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Zentalis Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Zentalis Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Zentalis Pharmaceuticals, Inc. announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$0.48 per share.

  • Is Zentalis Pharmaceuticals, Inc. Profitable?

    Zentalis Pharmaceuticals, Inc. reported -$160K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Zentalis Pharmaceuticals, Inc. EPS Next Year?

    Zentalis Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$2.33 per share to -$1.76 per share next year representing a decrease of -24.5%.

  • When is Zentalis Pharmaceuticals, Inc.'s Earnings Date?

    Zentalis Pharmaceuticals, Inc.'s next earnings date is March 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock